219 related articles for article (PubMed ID: 2339757)
41. Pathologic features of uterine leiomyomas following uterine artery embolization.
McCluggage WG; Ellis PK; McClure N; Walker WJ; Jackson PA; Manek S
Int J Gynecol Pathol; 2000 Oct; 19(4):342-7. PubMed ID: 11109163
[TBL] [Abstract][Full Text] [Related]
42. Glycogen metabolism of normal human myometrium and leiomyoma--possible hormonal control.
Milwidsky A; Gutman A
Gynecol Obstet Invest; 1983; 15(3):147-52. PubMed ID: 6403415
[TBL] [Abstract][Full Text] [Related]
43. Expression of terminally glycosylated calcitonin receptor-like receptor in uterine leiomyoma: endothelial phenotype and association with microvascular density.
Nikitenko LL; Cross T; Campo L; Turley H; Leek R; Manek S; Bicknell R; Rees MC
Clin Cancer Res; 2006 Oct; 12(19):5648-58. PubMed ID: 17020966
[TBL] [Abstract][Full Text] [Related]
44. Potential mechanisms of aberrant DNA hypomethylation on the x chromosome in uterine leiomyomas.
Sato S; Maekawa R; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Sugino N
J Reprod Dev; 2014 Mar; 60(1):47-54. PubMed ID: 24291816
[TBL] [Abstract][Full Text] [Related]
45. [Study on the local estrogen biosynthesis in human uterine leiomyoma].
Urabe M; Yamamoto T; Naito K; Kitawaki J; Honjo H; Okada H
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1229-36. PubMed ID: 2212823
[TBL] [Abstract][Full Text] [Related]
46. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth.
Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E
Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399
[TBL] [Abstract][Full Text] [Related]
47. Fibroblast growth factors (FGF) in human myometrium and uterine leiomyomas in various stages of tumour growth.
Wolańska M; Bańkowski E
Biochimie; 2006 Feb; 88(2):141-6. PubMed ID: 16139411
[TBL] [Abstract][Full Text] [Related]
48. CXCL12 Attracts Bone Marrow-Derived Cells to Uterine Leiomyomas.
Moridi I; Mamillapalli R; Kodaman PH; Habata S; Dang T; Taylor HS
Reprod Sci; 2020 Sep; 27(9):1724-1730. PubMed ID: 32020550
[TBL] [Abstract][Full Text] [Related]
49. Innervation of endometrium and myometrium in women with painful adenomyosis and uterine fibroids.
Zhang X; Lu B; Huang X; Xu H; Zhou C; Lin J
Fertil Steril; 2010 Jul; 94(2):730-7. PubMed ID: 19368910
[TBL] [Abstract][Full Text] [Related]
50. Liposarcoma arising in uterine lipoleiomyoma: a report of 3 cases and review of the literature.
McDonald AG; Dal Cin P; Ganguly A; Campbell S; Imai Y; Rosenberg AE; Oliva E
Am J Surg Pathol; 2011 Feb; 35(2):221-7. PubMed ID: 21263242
[TBL] [Abstract][Full Text] [Related]
51. [The estimation of LHRH receptors in the tissue of human leiomyoma, myometrium and endometrium].
Marinaccio M; Reshkin S; Pinto V; Paradiso A
Minerva Ginecol; 1994 Oct; 46(10):519-26. PubMed ID: 7838406
[TBL] [Abstract][Full Text] [Related]
52. Involvement of FKHR (FOXO1) transcription factor in human uterus leiomyoma growth.
Kovács KA; Lengyel F; Wilhelm F; Vértes Z; Sumegi B; Vértes M
Fertil Steril; 2010 Sep; 94(4):1491-1495. PubMed ID: 19772960
[TBL] [Abstract][Full Text] [Related]
53. Progesterone receptor action in leiomyoma and endometrial cancer.
Kim JJ; Sefton EC; Bulun SE
Prog Mol Biol Transl Sci; 2009; 87():53-85. PubMed ID: 20374701
[TBL] [Abstract][Full Text] [Related]
54. Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms.
Hricak H; Tscholakoff D; Heinrichs L; Fisher MR; Dooms GC; Reinhold C; Jaffe RB
Radiology; 1986 Feb; 158(2):385-91. PubMed ID: 3753623
[TBL] [Abstract][Full Text] [Related]
55. Growth potential of human uterine leiomyomas: some in vitro observations and their implications.
Cramer SF; Robertson AL; Ziats NP; Pearson OH
Obstet Gynecol; 1985 Jul; 66(1):36-41. PubMed ID: 3892387
[TBL] [Abstract][Full Text] [Related]
56. Changes in beta(2)-adrenoceptor expression and in adenylyl cyclase and phosphodiesterase activity in human uterine leiomyomas.
Adolfsson PI; Haug I; Berg G; Svensson SP
Mol Hum Reprod; 2000 Sep; 6(9):835-42. PubMed ID: 10956556
[TBL] [Abstract][Full Text] [Related]
57. Unusual morphological features of uterine leiomyomas treated with progestogens.
Boyd C; McCluggage WG
J Clin Pathol; 2011 Jun; 64(6):485-9. PubMed ID: 21398323
[TBL] [Abstract][Full Text] [Related]
58. Synthesis of catechol estrogens by human uterus and leiomyoma.
Reddy VV; Hanjani P; Rajan R
Steroids; 1981 Feb; 37(2):195-203. PubMed ID: 6261427
[TBL] [Abstract][Full Text] [Related]
59. Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays.
Malik M; Catherino WH
Fertil Steril; 2007 May; 87(5):1166-72. PubMed ID: 17222838
[TBL] [Abstract][Full Text] [Related]
60. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas.
Ip PP; Lam KW; Cheung CL; Yeung MC; Pun TC; Chan QK; Cheung AN
Am J Surg Pathol; 2007 Aug; 31(8):1215-24. PubMed ID: 17667546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
